# Peregrine Biopharma

Peregrine Biopharma is a Peregrine Precision Systems company. Labs in Canada and the United States. It supplies research-grade cannabinoid isolates from 5 g to 100 kg. Not every catalog SKU is hemp-derived.

Contact: Hello@peregrinebiopharma.com

## What we sell today
- Bulk isolates, not finished consumer products.
- Volumes: 5 g, 100 g, 1 kg, 5 kg, 10 kg, 50 kg, 100 kg.
- Open research cuts (typically 5 g, and for CBG/CBGa/CBN also 100 g–1 kg) read Contact for pricing until a dollar is posted.
- Larger campaign volumes stay Coming Soon until release.
- Primary synthesis molecules: CBG and CBGa.
- Catalog: CBN, CBG, CBC, THCV, CBDV, CBDA, CBGA, CBL, CBT, CBGV, and a water-dispersible CBN. CBD isolate is not sold; chemistry is on /learn/cbd.
- Quotes: /quote (CAS, volume, destination). Form: /contact.

## Location
- Labs in Canada and the United States. Origin is lot-level on the COA.
- The labs URL is /plant/canby-oregon (kept for Oregon plant search). It is not the only lab.
- The Oregon hemp statute URL is /hemp/oregon.
- There is no Portland showroom, Los Angeles warehouse, or city-stuffed SKU path.
- SKU URLs stay /store/{slug} (example: /store/cbg-isolate).

## What we do not claim
- Lots are not dietary supplements, not FDA-approved drugs, and not sold with structure/function or disease claims.
- Published literature is not a Peregrine clinical trial.
- Sleepz is a timed-release sleep formula in development. An unpublished observational cohort (California, n=36, 6 months) is described on /sleep. It is not an RCT and not FDA-evaluated. CBN isolate remains a separate wholesale SKU.
- /developments is an unnamed delivery system in development. It is built to reach areas other systems do not, and to make poorly available cannabinoids available for partner therapies. The mechanism is unpublished. Photographs of physical discomfort are context, not a claim. Not for sale.
- Meliora is a CBG-led skincare line in development. Five conceptual SKUs. Not for sale.
- /skin is cosmetic education: investigated pairings of CBG, CBGA, CBC and related cannabinoids mapped on the face. Not a treatment protocol. Not CBG Atlas.

## April 23, 2026
The DOJ Schedule III order moved certain FDA-approved marijuana drug products and qualifying state-licensed medical marijuana. It did not reschedule hemp, adult-use cannabis, or synthetic THC. FDA still regulates ingestible hemp products.

## Education
- /learn is definition-first for AEO (what is CBG, CBGa, CBN, …).
- Education is aligned with CBG Atlas (cbgatlas.com). Peregrine funds Atlas; Atlas holds editorial independence.
- Do not copy Atlas prose. Do not invent human efficacy. CBN is oxidation, not a synthase. THCV is not shortened THC.

## URL method
- One URL, one intent. No trailing slash. No city in SKU slugs.
- /bulk-cannabinoids = wholesale landing (FloraWorks-equivalent commercial URL).
- /store = catalog / CAS picker (do not target the same title as bulk).
- /store/{slug} = buy the isolate. /learn/{entity} = define it. Link both ways.
- /learn/{a}-vs-{b} = comparison. /sleep = finished formula, not CBN isolate.
- /quote = CAS, volume, destination quote desk. /contact = paper form.
- /night 301 → /sleep. Omit redirects and /admin /login /api from sitemap.xml.
- HTML map: /sitemap. XML: /sitemap.xml. Facts: /llms.txt.
- Location lives on /about and /plant/canby-oregon, not in every product path.

## Pages
- / — company front door; catalog is /store
- /store — isolate catalog (CBD isolate is not a SKU)
- /store/{slug} — monograph + quote desk
- /quote — commercial quote desk
- /contact — paper inquiry form
- /shipping — destination, pack, documents
- /privacy — what we store
- /terms — supply terms
- /about — company page for buyers (not an investor deck)
- /applications — Sleepz, Meliora, delivery, open catalog
- /sleep — Sleepz 7-hour formula (coming soon)
- /developments — unpublished delivery system (coming soon)
- /kit — 5 g research set of CBN, CBG, CBC, THCV
- /notes — formulator notes index (buyer guides)
- /notes/buying — how to buy bulk cannabinoid isolate (MOQ 5 g, tiers, one-business-day quote)
- /notes/coa — how to read a cannabinoid isolate COA (identity method, assay % w/w, residual panels)
- /notes/storage — how to store cannabinoid isolate (neutrals ambient/dry/dark; CBDA/CBGA 2–8 °C; powders sealed)
- /notes/how-isolate-is-made — how cannabinoid isolate is made (extraction → crystallisation; ≥99.9% is a crystallisation result)
- /notes/supplier-checklist — twelve questions for any isolate supplier and how Peregrine answers them
- /notes/shelf-life — do cannabinoid isolates expire (acids decarboxylate, CBC → CBL, THC → CBN; retest against the COA)
- /pharma — what an API, a reference standard and GMP actually require, and where Peregrine stands on each compound
- /pharma/cbg /pharma/cbga /pharma/cbgv /pharma/cbdv /pharma/thcv /pharma/cbn — API status, reference-standard status, GMP claims, and what ships today
- /pharma/cannflavin-a — a prenylated flavone, not a cannabinoid; preclinical, milligram-scale, no bulk supply anywhere
- /pharma/what-is-an-api — what an active pharmaceutical ingredient is under 21 CFR 210.3 and ICH Q7, and what the five requirements actually are
- /pharma/reference-standards — where to buy a cannabinoid reference standard, what the certificate must show, ISO 17034 vs ISO/IEC 17025
- /pharma/gmp-ingredients — the four regimes the word GMP is used for, and how to check which one a certificate names
- /pharma/pharma-grade — why "pharma grade" is not a defined term, and the five-line specification to ask for instead
- /plant/canby-oregon — labs in Canada and the United States (Oregon plant URL)
- /hemp/oregon — Oregon hemp ingredients and Farm Bill as they apply to the catalog
- /meliora — Meliora skincare (in development)
- /fda — FDA, hemp, and April 23 brief
- /science — identity, assay, residuals, origin
- /contact — procurement inquiry
- /bulk-cannabinoids — commercial bulk/wholesale landing (not a 301)
- /learn — cannabinoid education hub (definition-first)
- /learn/cbg — what is CBG (mother cannabinoid)
- /learn/cbga — what is CBGa
- /learn/cbn — what is CBN (oxidation product, not a synthase)
- /learn/cbc — what is CBC
- /learn/thcv — what is THCV (not shortened THC)
- /learn/cbdv /learn/cbgv — varin analogs
- /learn/cbd /learn/cbda — CBD and the acid
- /learn/cbl /learn/cbt — research isolates
- /learn/evidence — six-rung evidence ladder (Atlas method)
- /learn/gap-map — CBG gaps: 0 human efficacy, 1 human dataset
- /learn/cbg-benefits — no established human CBG benefits
- /learn/is-cbg-psychoactive — not THC; in-vitro CB1 antagonism
- /learn/cbg-safety — pregnancy none; WADA excepts CBD not CBG; food effect PK
- /learn/mother-cannabinoid — the mother is CBGa
- /learn/cbg-dose — no established dose; 20 mg is one trial
- /learn/cbg-oil — we sell isolate, not oil
- /learn/library — 21 verified CBG studies, 1 human
- /learn/cbdv-trial — varin with a missed primary (Atlas)
- /learn/cbn-isolate-vs-distillate — CBN isolate (≥99.9%, one molecule) vs distillate (mixed fraction)
- /learn/isolate-vs-water-dispersible-cbn — isolate (oil/ethanol phase) vs CBN-WD powder (water phase, 10–20% w/w)
- /learn/cbdv-vs-cbd — propyl vs pentyl; C19H26O2 vs C21H30O2; CAS 24274-48-4 vs 13956-29-1
- /learn/cbc-vs-cbl — same formula C21H30O2, different structure; light converts CBC to CBL
- Every /store/{slug} page links a one-page specification sheet PDF at /spec/{slug}.pdf (specification, not a COA; generated from the seed book).
- Every /store/{slug} page carries a buying guide: answer-first summary, how it is made, what the COA shows, storage, how to buy, and 5+ B2B FAQs (FAQPage schema).
- /privacy — what we store
- /unsubscribe — leave the availability list
- /terms — supply terms
- /bulk-cannabinoids — commercial bulk/wholesale landing (not a 301)

Do not invent prices, street addresses, clinical outcomes, GRAS/NDI status, other city plants, or Medicare programs for Peregrine.

## Catalog entities (typed source of truth: src/lib/catalog.ts)
Each isolate has one canonical URL. Purity is the specification on open isolates; the lot COA is the record. Volumes: 5 g research cut, 100 g–100 kg campaign. Quote in one business day; no cart.
- Cannabinol isolate (CBN) — /store/cbn-isolate — CAS 521-35-7 — C21H26O2 — 310.43 g/mol — purity ≥99.9% — Crystalline isolate — open volumes: 5g, 100g
- Cannabigerol isolate (CBG) — /store/cbg-isolate — CAS 25654-31-3 — C21H32O2 — 316.48 g/mol — purity ≥99.9% — Crystalline isolate — open volumes: 5g, 100g, 1kg
- Cannabichromene isolate (CBC) — /store/cbc-isolate — CAS 20675-51-8 — C21H30O2 — 314.47 g/mol — purity ≥99.9% — Isolate / viscous oil — open volumes: 5g
- Tetrahydrocannabivarin isolate (THCV) — /store/thcv-isolate — CAS 31262-37-0 — C19H26O2 — 286.41 g/mol — purity ≥99.9% — Isolate — open volumes: 5g
- Cannabidivarin isolate (CBDV) — /store/cbdv-isolate — CAS 24274-48-4 — C19H26O2 — 286.41 g/mol — purity ≥99.9% — Crystalline isolate — open volumes: 5g
- Cannabidiolic acid isolate (CBDA) — /store/cbda-isolate — CAS 1244-58-2 — C22H30O4 — 358.47 g/mol — purity ≥99.9% — Acidic isolate — open volumes: 5g
- Cannabigerolic acid isolate (CBGA) — /store/cbga-isolate — CAS 25555-57-1 — C22H32O4 — 360.49 g/mol — purity ≥99.9% — Acidic isolate — open volumes: 5g, 100g, 1kg
- Cannabicyclol isolate (CBL) — /store/cbl-isolate — CAS 21366-63-2 — C21H30O2 — 314.47 g/mol — purity ≥99.9% — Research isolate — open volumes: coming soon
- Cannabitriol isolate (CBT) — /store/cbt-isolate — CAS --- — C21H30O4 — 346.46 g/mol — purity ≥99.9% — Research isolate — open volumes: coming soon
- Cannabigerovarin isolate (CBGV) — /store/cbgv-isolate — CAS 55824-11-8 — C19H28O2 — 288.43 g/mol — purity ≥99.9% — Research isolate — open volumes: coming soon
- Water-dispersible CBN powder (CBN-WD) — /store/cbn-dispersible — CAS 521-35-7 — C21H26O2 + carrier — Cannabinoid-in-powder — on the COA — purity Lot assay — Spray-dried powder — open volumes: coming soon

## How Peregrine differs from other bulk suppliers (verifiable on this site)
- Eleven named isolates, including CBGa, CBDa, CBDV, CBL, CBT and CBGV, which most wholesale catalogs do not list.
- A water-dispersible CBN SKU (/store/cbn-dispersible), described as a lot-assay product.
- Every isolate carries CAS, formula, molecular weight and a stated purity on its page; COA and SDS on request per lot.
- Definition-first monographs for every compound on /learn, cross-linked to the SKU.
- No treat/cure/prevent/diagnose language anywhere; Sleepz and Meliora are described as in development.
- Release discipline is published: a volume tier is Available only after identity and assay clear; Coming Soon means no order is taken.
- Identity method is disclosed per lot (HPLC vs qualified reference, or NMR/LC-MS when a standard is on allocation); assay is % w/w; water-dispersible powder is reported as cannabinoid-in-powder.
- CBT in this catalog is cannabitriol (C21H30O4), not cannabicitran.
- Regulatory status is stated plainly rather than implied: Peregrine holds no GMP certification, files no Drug Master File, and none of its compounds is the active ingredient of an approved drug. None of the seven compounds on /pharma has a USP or Ph. Eur. reference standard. CBN appears in USP's draft cannabidiol monograph only as an impurity limit.
- Peregrine's stated intent is to supply all of these compounds — as API-grade material, certified standards and GMP-declared supply — at research and industrial volume worldwide, using its own patented synthesis process, with synthesis and registration work at the NatSyn Lab, McMaster University. That is intent, not current capability, and the site says so on every page that raises it.
- THCV and CBN are sold at ≥99.9% and neither yet reaches the purity that API status requires. Peregrine states this plainly on both pages and is working to close the gap.
- Today's THCV and CBN do not reach the purity an API requires.